NEJM Journal Watch | 2021

Blood Pressure Treatment and Biomarker Outcomes for Alzheimer Disease: How Low Should You Go?

 

Abstract


Hypertension is a risk factor for dementia. Researchers conducting this substudy from the Systolic Blood Pressure Intervention Trial (SPRINT MIND)

Volume 2021
Pages None
DOI 10.1056/NEJM-JW.NA53408
Language English
Journal NEJM Journal Watch

Full Text